ロード中...
Metabolic interactions between cysteamine and epigallocatechin gallate
Phase II clinical trials indicate that the combination of cysteamine plus epigallocatechin gallate (EGCG) is effective against cystic fibrosis in patients bearing the most frequent etiological mutation (CFTRΔF508). Here, we investigated the interaction between both agents on cultured respiratory epi...
保存先:
| 出版年: | Cell Cycle |
|---|---|
| 主要な著者: | , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Taylor & Francis
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5323035/ https://ncbi.nlm.nih.gov/pubmed/28059601 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384101.2016.1249550 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|